Inventor
SUN CECILY R Y
US33 patents
⚠️ This page may combine multiple inventors who share the name “SUN CECILY R Y”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TANOX INC
8 patentsUS6956107B2Oct 18, 2005
Inhibitors of complement activation
TANOX INC110 citations97
US6534058B2Mar 18, 2003
Anti-C5 monoclonal antibodies
TANOX INC94 citations97
US7112327B2Sep 26, 2006
Inhibition of complement activation
TANOX INC56 citations96
US6998468B2Feb 14, 2006
Anti-C2/C2a inhibitors of complement activation
TANOX INC46 citations96
US6309880B1Oct 30, 2001
Antibodies specific for CD4-binding domain of HIV-1
TANOX INC18 citations92
US5981278ANov 9, 1999
Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
TANOX INC20 citations92
US5854400ADec 29, 1998
Monoclonal antibodies which neutralize HIV-1 infection
TANOX INC36 citations92
US6657050B1Dec 2, 2003
Chimeric viral-neutralizing immunoglobulins
TANOX INC11 citations74
GENENTECH INC
7 patentsUS7943135B2May 17, 2011
Method of treatment using anti-factor D antibodies
GENENTECH INC27 citations96
US7432356B2Oct 7, 2008
Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
GENENTECH INC82 citations96
US8383802B2Feb 26, 2013
Nucleic acids encoding antibodies that bind factor D
GENENTECH INC12 citations92
US7439331B2Oct 21, 2008
Inhibition of complement activation
GENENTECH INC43 citations92
US8372404B2Feb 12, 2013
Anti-C5/C5a antibodies and methods of use
GENENTECH INC27 citations91
US8765131B2Jul 1, 2014
Methods of inhibiting alternative pathway complement activation with anti-factor D antibodies
GENENTECH INC7 citations83
US8907072B2Dec 9, 2014
Nucleic acids encoding antibody 137-26 which binds C5 and C5a
GENENTECH INC6 citations82
TANOX BIOSYSTEMS INC
6 patentsUS5245015ASep 14, 1993
Monoclonal antibodies which neutralize HIV-1 through reaction with a conformational epitope in vitro
TANOX BIOSYSTEMS INC53 citations96
US5266478ANov 30, 1993
Antibodies which target a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120
TANOX BIOSYSTEMS INC24 citations92
US5739306AApr 14, 1998
gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
TANOX BIOSYSTEMS INC12 citations82
US5728814AMar 17, 1998
GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
TANOX BIOSYSTEMS INC7 citations74
US5691447ANov 25, 1997
GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
TANOX BIOSYSTEMS INC0 citations52
US5652333AJul 29, 1997
gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
TANOX BIOSYSTEMS INC0 citations52
SUN LEE-HWEI K
4 patentsUS7030226B2Apr 18, 2006
Fc fusion proteins of human erythropoietin with increased biological activities
SUN LEE-HWEI K183 citations97
US7250493B2Jul 31, 2007
FC fusion proteins of human erythropoietin with increased biological activities
SUN LEE-HWEI K17 citations91
US7226759B2Jun 5, 2007
Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities
SUN LEE-HWEI K27 citations91
US7232668B2Jun 19, 2007
Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities
SUN LEE-HWEI K3 citations61
FUNG MICHAEL S C
4 patentsUS8236317B2Aug 7, 2012
Methods of treating with anti-factor D antibodies
FUNG MICHAEL S C15 citations92
US8221756B2Jul 17, 2012
Complement inhibitors and uses thereof
FUNG MICHAEL S C24 citations92
US8124090B2Feb 28, 2012
Anti-factor D antibodies and methods of treatment
FUNG MICHAEL S C24 citations92
US8911735B2Dec 16, 2014
Complement inhibitors and uses thereof
FUNG MICHAEL S C3 citations62